NORTH AMERICA TOXICOLOGY LABORATORIES MARKET ANALYSIS

Market Challenges And Opportunities

North America Toxicology Laboratories Market- Restraint

Introduction of Point-Of-Care Toxicology Testing Devices

Introduction of point-of-care toxicology testing devices is expected to hamper the market growth. Increasing abusive or hazardous consumption of controlled substances leads to high demand for handheld toxicology testing devices. Thus, companies are focusing on developing point-of-care toxicology testing devices. Commercialization of point-of-care toxicology The market share of traditional toxicology laboratories would eventually be taken over by testing devices, which could have a negative effect on the market's expansion. For instance, in April 2019, Neogen Corporation, launched a portable version of its Raptor Integrated Analysis Platform that offers the option of performing mycotoxin testing in the laboratory or wherever a tester may choose.

Introduction of Point-Of-Care Toxicology Testing Devices

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.